A study in 30 AML patients showed that elevated serum levels of the insulin-like growth factor binding protein (IGFBP) family were associated with worse progression-free survival and overall survival, suggesting that outcomes in myeloid leukemias may be influenced by IGFBPs, probably mediated through the alteration of IGF-1R activation [136]. Here, IGF1R is linked to acute myeloid leukemia.